Related references
Note: Only part of the references are listed.Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies
C. A. Kohler et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression
J. C. Felger et al.
MOLECULAR PSYCHIATRY (2016)
Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [C-11]PBR28 PET Brain Imaging Study
Peter S. Bloomfield et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression
Kymberly D. Young et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Elevated C-reactive protein and late-onset bipolar disorder in 78 809 individuals from the general population
Marie Kim Wium-Andersen et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
Does psychosis increase the risk of suicide in patients with major depression? A systematic review
Isheeta Zalpuri et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients
Lilly Schwieler et al.
JOURNAL OF NEUROINFLAMMATION (2016)
TDO as a therapeutic target in brain diseases
Cheng-Peng Yu et al.
METABOLIC BRAIN DISEASE (2016)
Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis
S. Georgin-Lavialle et al.
MOLECULAR PSYCHIATRY (2016)
Cortisol awakening response in patients with psychosis: Systematic review and meta-analysis
Maximus Berger et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H. Miller et al.
NATURE REVIEWS IMMUNOLOGY (2016)
A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality
Cecilie Bay-Richter et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder
Jonathan Savitz et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
Rita Haapakoski et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
C-Reactive Protein Alterations in Bipolar Disorder: A Meta-Analysis
Aroldo A. Dargel et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Glutamate and dopamine in schizophrenia: An update for the 21st century
Oliver Howes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder
Jonathan Savitz et al.
PSYCHONEUROENDOCRINOLOGY (2015)
Much ado about much: Stress, dynamic biomarkers and HPA axis dysregulation along the trajectory to psychosis
Jai L. Shah et al.
SCHIZOPHRENIA RESEARCH (2015)
Role of Translocator Protein Density, a Marker of Neuroinflammation, in the Brain During Major Depressive Episodes
Elaine Setiawan et al.
JAMA PSYCHIATRY (2015)
The organization of the stress system and its dysregulation in depressive illness
P. W. Gold
MOLECULAR PSYCHIATRY (2015)
Putative Neuroprotective and Neurotoxic Kynurenine Pathway Metabolites Are Associated with Hippocampal and Amygdalar Volumes in Subjects with Major Depressive Disorder
Jonathan Savitz et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Are people at risk of psychosis also at risk of suicide and self-harm? A systematic review and meta-analysis
P. J. Taylor et al.
PSYCHOLOGICAL MEDICINE (2015)
Peripheral Inflammation Acutely Impairs Human Spatial Memory via Actions on Medial Temporal Lobe Glucose Metabolism
Neil A. Harrison et al.
BIOLOGICAL PSYCHIATRY (2014)
Neuroinflammation in bipolar disorder - A [11C]-(R)-PK11195 positron emission tomography study
Bartholomeus C. M. (Benno) Haarman et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression
C. Lavebratt et al.
MOLECULAR PSYCHIATRY (2014)
Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment
Lot de Witte et al.
SCHIZOPHRENIA RESEARCH (2014)
Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis
Rachel Upthegrove et al.
SCHIZOPHRENIA RESEARCH (2014)
Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life A Population-Based Longitudinal Study
Golam M. Khandaker et al.
JAMA PSYCHIATRY (2014)
Kynurenines in CNS disease: regulation by inflammatory cytokines
Brian M. Campbell et al.
FRONTIERS IN NEUROSCIENCE (2014)
Varicella Zoster Virus-Specific Immune Responses to a Herpes Zoster Vaccine in Elderly Recipients With Major Depression and the Impact of Antidepressant Medications
Michael R. Irwin et al.
CLINICAL INFECTIOUS DISEASES (2013)
Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: Cytokine challenge increases production of 3-hydroxykynurenine
Anne-Sofie Johansson et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Klaus Munkholm et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Connecting Inflammation with Glutamate Agonism in Suicidality
Sophie Erhardt et al.
NEUROPSYCHOPHARMACOLOGY (2013)
NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
Adam K. Walker et al.
NEUROPSYCHOPHARMACOLOGY (2013)
INFLAMMATORY CYTOKINES IN DEPRESSION: NEUROBIOLOGICAL MECHANISMS AND THERAPEUTIC IMPLICATIONS
J. C. Felger et al.
NEUROSCIENCE (2013)
3-Hydroxykynurenine: An intriguing molecule exerting dual actions in the Central Nervous System
Ana Laura Colin-Gonzalez et al.
NEUROTOXICOLOGY (2013)
An expanding range of targets for kynurenine metabolites of tryptophan
Trevor W. Stone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Boundaries of Schizoaffective Disorder Revisiting Kraepelin
Roman Kotov et al.
JAMA PSYCHIATRY (2013)
Dopaminergic Mechanisms of Reduced Basal Ganglia Responses to Hedonic Reward During Interferon Alfa Administration
Lucile Capuron et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder
Sara K. Olsson et al.
BIPOLAR DISORDERS (2012)
Quinolinic acid, the inescapable neurotoxin
Gilles J. Guillemin
FEBS JOURNAL (2012)
Can bipolar disorder be viewed as a multi-system inflammatory disease?
Marion Leboyer et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio
Tomasz Kocki et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Glucose Metabolism in the Insula and Cingulate Is Affected by Systemic Inflammation in Humans
Jonas Hannestad et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Exposure to Kynurenic Acid During Adolescence Produces Memory Deficits in Adulthood
Cynthia O. Akagbosu et al.
SCHIZOPHRENIA BULLETIN (2012)
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Klas R. Linderholm et al.
SCHIZOPHRENIA BULLETIN (2012)
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Brian J. Miller et al.
BIOLOGICAL PSYCHIATRY (2011)
Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naive and medication-free schizophrenic patients
A. M. Myint et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Immune suppression and immune activation in depression
Joshua Blume et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?
Johann Steiner et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory
Ana Pocivavsek et al.
NEUROPSYCHOPHARMACOLOGY (2011)
The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
M. Maes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Inflammation-associated depression: From serotonin to kynurenine
Robert Dantzer et al.
PSYCHONEUROENDOCRINOLOGY (2011)
Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders
Thomas Insel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Inflammation-Induced Anhedonia: Endotoxin Reduces Ventral Striatum Responses to Reward
Naomi I. Eisenberger et al.
BIOLOGICAL PSYCHIATRY (2010)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Depression and immunity: A role for T cells?
Andrew H. Miller
BRAIN BEHAVIOR AND IMMUNITY (2010)
Association of high-sensitivity C-reactive protein with de novo major depression
Julie A. Pasco et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder
Sara K. Olsson et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2010)
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
C. L. Raison et al.
MOLECULAR PSYCHIATRY (2010)
Inflammation Causes Mood Changes Through Alterations in Subgenual Cingulate Activity and Mesolimbic Connectivity
Neil A. Harrison et al.
BIOLOGICAL PSYCHIATRY (2009)
The Effects of Undertreated Chronic Medical Illnesses in Patients With Severe Mental Disorders
Andrea Fagiolini et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
Janine Doorduin et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
J. C. O'Connor et al.
MOLECULAR PSYCHIATRY (2009)
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
M. Bryant Howren et al.
PSYCHOSOMATIC MEDICINE (2009)
Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study
Bart N. van Berckel et al.
BIOLOGICAL PSYCHIATRY (2008)
Exploring the borders of the schizoaffective spectrum: A categorical and dimensional approach
Victor Peralta et al.
JOURNAL OF AFFECTIVE DISORDERS (2008)
Role of depression, stress, and trauma in HIV disease progression
Jane Leserman
PSYCHOSOMATIC MEDICINE (2008)
Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: A pharmacological analysis
Klas R. Linderholm et al.
NEUROPHARMACOLOGY (2007)
Tryptophan breakdown pathway in bipolar mania
Aye Mu Myint et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Depressive disorders and immunity: 20 years of progress and discovery
Michael R. Irwin et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Kynurenine pathway in major depression:: Evidence of impaired neuroprotection
Aye-Mu Myint et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Suicidality in first episode psychosis
Mary Clarke et al.
SCHIZOPHRENIA RESEARCH (2006)
Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia
LK Nilsson et al.
SCHIZOPHRENIA RESEARCH (2005)
IDO and interferon-α-induced depressive symptoms:: a shift in hypothesis from tryptophan depletion to neurotoxicity
MC Wichers et al.
MOLECULAR PSYCHIATRY (2005)
Science and society - Stress-induced immune dysfunction: implications for health
R Glaser et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy
L Capuron et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression
AM Myint et al.
MEDICAL HYPOTHESES (2003)
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans
M Wichers et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2002)
Treatment of cytokine-induced depression
L Capuron et al.
BRAIN BEHAVIOR AND IMMUNITY (2002)
Neopterin production, tryptophan degradation, and mental depression - What is the link?
B Widner et al.
BRAIN BEHAVIOR AND IMMUNITY (2002)
OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis - One-year follow-up of a randomised controlled trial
M Nordentoft et al.
BRITISH JOURNAL OF PSYCHIATRY (2002)
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states
PW Gold et al.
MOLECULAR PSYCHIATRY (2002)
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy
L Capuron et al.
MOLECULAR PSYCHIATRY (2002)
Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms
S Bonaccorso et al.
PSYCHIATRY RESEARCH (2001)
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
S Erhardt et al.
NEUROSCIENCE LETTERS (2001)
Increased cortical kynurenate content in schizophrenia
R Schwarcz et al.
BIOLOGICAL PSYCHIATRY (2001)
The relationship of depression and stressors to immunological assays: A meta-analytic review
EP Zorrilla et al.
BRAIN BEHAVIOR AND IMMUNITY (2001)
Share Paper
